Compare SIF & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIF | CLGN |
|---|---|---|
| Founded | 1913 | 2004 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 18.4M |
| IPO Year | 1995 | 2015 |
| Metric | SIF | CLGN |
|---|---|---|
| Price | $13.27 | $0.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 156.2K | 99.5K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.67 | N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $111,212,000.00 | N/A |
| Revenue This Year | N/A | $1,596.12 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $44.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.33 | $0.50 |
| 52 Week High | $15.00 | $4.98 |
| Indicator | SIF | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 34.59 |
| Support Level | $5.92 | $0.50 |
| Resistance Level | N/A | $1.60 |
| Average True Range (ATR) | 1.38 | 0.08 |
| MACD | -0.13 | 0.04 |
| Stochastic Oscillator | 65.25 | 63.40 |
SIFCO Industries Inc produces forgings, sub-assemblies, and machined components for the Aerospace and Energy markets. Its services include forging, heat treating, machining, surface treatment, non-destructive testing, and sub-assembly of forged components. The company manufactures envelopes and precision forgings, as well as rough and finished machined parts, serving OEMs, Tier 1 and Tier 2 suppliers, and aftermarket providers across Aerospace, Defense, Energy, and Commercial Space. Its Products are made from steel, high-temperature alloys, nickel alloys, titanium, and aluminum, and include components for aircraft and industrial gas turbine engines, airframe structures, landing gear, wheels and brakes, helicopter rotating parts, and other commercial and industrial applications.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.